ALGS (Aligos Therapeutics, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q2'26, revenue estimate is 24.68 million USD with EPS (earnings per share) anticipated at (1.09) USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported965.00 K741.00 K169.00 K2.83 M— | Revenue Estimate433.33 K500.00 K440.00 K250.00 K24.68 M | Revenue Surprise+122.69%+48.20%-61.59%+1032.00% | EPS Reported(1.53)(3.04)(1.91)(2.21) | EPS Estimate(2.36)(1.90)(2.49)(2.21)(1.09) | EPS Surprise+35.26%-59.99%+23.19%+0.15% |